Skin as outermost immune organ of vertebrates that elicits robust early immune responses after immunization with glycoprotein of spring viraemia of carp virus.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE

Original Publication: San Francisco, CA : Public Library of Science, c2005-

Zebrafish*/immunology ; Skin*/immunology ; Skin*/metabolism ; Fish Diseases*/immunology ; Fish Diseases*/prevention & control ; Fish Diseases*/virology ; Rhabdoviridae*/immunology ; Rhabdoviridae Infections*/immunology ; Rhabdoviridae Infections*/prevention & control; Animals ; Glycoproteins/immunology ; Immunization ; Viral Vaccines/immunology ; Vaccination

Competing Interests: The authors have declared that no competing interests exist.
As the outermost immune organ in vertebrates, the skin serves as the primary interface with the external environment and plays a crucial role in initiating the early immune response. The skin contains a variety of immune cells that induce mucosal and systemic immune responses, rendering it a prime target for vaccination strategies. Insight into the mechanisms through which vaccination triggers early immune responses is paramount for advancing animal and human health, yet our current understanding remains limited. Given its significance in vertebrate evolution, teleost fish emerges as an excellent model for investigating the early immune response of skin. In this study, we demonstrate that significant quantities of vaccine can be absorbed by the skin and transported to the body through dermis and muscle metabolism by immerses immune zebrafish with glycoprotein of spring viraemia of carp virus. Immersion immunization can elicit robust and enduring immune protection, with the skin triggering a potent immune response early in the immunization process. Analysis of the skin transcriptome revealed the involvement of numerous immune-related genes in the immersion immune response, with indications that HSP70 and MAPK signals might play pivotal roles in the immune process induced by glycoprotein. Co-immunoprecipitation and cell co-localization studies confirmed the interaction between glycoprotein and HSP70. Subsequent research demonstrated that overexpression or inhibition of HSP70 could respectively enhance or impede the expression of JNK and related proteins. However, the survival rate and immune response of HSP70 inhibited zebrafish with glycoprotein treatment were significantly reduced. These findings propose that the interaction between glycoprotein and HSP70 may activate JNK, thereby modulating mucosal and systemic immune responses induced by glycoprotein. This investigation offers novel insights and a foundational understanding of early skin immune reactions.
(Copyright: © 2024 Zhao et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)

Mar Drugs. 2022 Feb 17;20(2):. (PMID: 35200674)
Mol Immunol. 2010 Jan;47(4):738-46. (PMID: 19931913)
Immunobiology. 2014 Nov;219(11):850-8. (PMID: 25113416)
Fish Shellfish Immunol. 2022 Sep;128:436-446. (PMID: 35985626)
J Immunol. 2024 Feb 15;212(4):551-562. (PMID: 38197664)
Fish Shellfish Immunol. 2015 Aug;45(2):517-27. (PMID: 25957883)
Nat Commun. 2016 Feb 12;7:10728. (PMID: 26869478)
J Fish Dis. 2021 Oct;44(10):1587-1594. (PMID: 34165796)
Pharm Res. 2017 Nov;34(11):2223-2240. (PMID: 28718050)
Int J Hyperthermia. 2002 Nov-Dec;18(6):563-75. (PMID: 12537755)
Virus Res. 2022 Oct 15;320:198896. (PMID: 35977626)
J Gen Virol. 2016 May;97(5):1037-1051. (PMID: 26905065)
Vaccine. 2013 May 1;31(19):2403-15. (PMID: 23523401)
Immunology. 2021 Jan;162(1):105-120. (PMID: 32979273)
J Dermatol Sci. 2016 Apr;82(1):38-45. (PMID: 26674124)
PLoS Pathog. 2018 Nov 5;14(11):e1007251. (PMID: 30395648)
J Natl Cancer Inst. 2015 Nov 22;108(3):. (PMID: 26598503)
Neurochem Int. 2011 Jul;58(8):888-95. (PMID: 21338645)
Proc Natl Acad Sci U S A. 2005 May 10;102(19):6919-24. (PMID: 15863615)
Antiviral Res. 2022 Jul;203:105346. (PMID: 35605698)
Int J Mol Sci. 2021 Aug 29;22(17):. (PMID: 34502274)
Int J Mol Med. 2018 Oct;42(4):2089-2097. (PMID: 30066840)
J Virol. 2015 Jan;89(1):61-70. (PMID: 25320288)
Front Immunol. 2019 Oct 10;10:2292. (PMID: 31649660)
Neuroscience. 2018 Apr 01;375:108-118. (PMID: 29374537)
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2501-6. (PMID: 12606718)
Nat Immunol. 2010 Sep;11(9):827-35. (PMID: 20676094)
Methods Mol Biol. 2023;2693:193-208. (PMID: 37540436)
Fish Shellfish Immunol. 2020 Nov;106:1052-1066. (PMID: 32950679)
Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):13097-102. (PMID: 23884653)
Antioxidants (Basel). 2023 Jul 18;12(7):. (PMID: 37507982)
Fish Shellfish Immunol. 2018 Oct;81:438-444. (PMID: 29680490)
Fish Shellfish Immunol. 2022 Aug;127:866-875. (PMID: 35850458)
Mol Cell Biol. 2018 Nov 28;38(24):. (PMID: 30275345)
Fish Shellfish Immunol. 2019 Feb;85:66-77. (PMID: 29567136)
Antiviral Res. 2020 Feb;174:104672. (PMID: 31825851)
J Nanobiotechnology. 2020 Jan 30;18(1):24. (PMID: 32000788)
Expert Rev Proteomics. 2005 Oct;2(5):809-20. (PMID: 16209658)
Immunol Lett. 2010 Feb 16;128(2):98-104. (PMID: 19900479)
Dev Comp Immunol. 2014 Feb;42(2):138-47. (PMID: 24001581)
J Immunol. 2021 Mar 1;206(5):1088-1101. (PMID: 33495235)
Arch Immunol Ther Exp (Warsz). 2018 Feb;66(1):45-54. (PMID: 28623375)
Arch Virol. 2007;152(8):1457-65. (PMID: 17447109)
Nat Immunol. 2005 Mar;6(3):295-302. (PMID: 15685175)
J Virol. 2023 Apr 27;97(4):e0005023. (PMID: 36975794)
Sci Immunol. 2020 Feb 7;5(44):. (PMID: 32034088)
Front Immunol. 2017 Oct 24;8:1340. (PMID: 29114248)
Nat Biotechnol. 2013 Dec;31(12):1082-5. (PMID: 24316643)
ACS Appl Mater Interfaces. 2024 Jan 10;16(1):228-244. (PMID: 38055273)
Nat Rev Immunol. 2002 Sep;2(9):688-98. (PMID: 12209137)
Fish Shellfish Immunol. 2019 Nov;94:833-841. (PMID: 31580936)
Vaccine. 2024 Apr 19;42(11):2886-2894. (PMID: 38519342)
Acta Biomater. 2024 Jan 15;174:386-399. (PMID: 38016511)
Nat Rev Immunol. 2007 Mar;7(3):202-12. (PMID: 17318231)
J Cell Mol Med. 2008 Jun;12(3):743-61. (PMID: 18266962)
Front Immunol. 2020 Oct 02;11:567941. (PMID: 33123139)
Vaccines (Basel). 2021 Oct 29;9(11):. (PMID: 34835184)
Methods. 2001 Dec;25(4):402-8. (PMID: 11846609)
Cell Discov. 2022 Apr 5;8(1):31. (PMID: 35379790)
J Exp Zool B Mol Dev Evol. 2014 Sep;322(6):438-63. (PMID: 24464682)
Vaccine. 2021 Mar 26;39(13):1857-1869. (PMID: 33678451)
NPJ Vaccines. 2022 Sep 6;7(1):106. (PMID: 36068296)
Expert Rev Pharmacoecon Outcomes Res. 2018 Jun;18(3):267-275. (PMID: 29347854)
J Fish Dis. 2010 Oct;33(10):789-801. (PMID: 20678104)
Int J Mol Sci. 2023 Jul 08;24(14):. (PMID: 37511003)
Front Immunol. 2021 Feb 16;11:622377. (PMID: 33664735)
Front Immunol. 2020 Jun 12;11:988. (PMID: 32595634)
Eur Arch Otorhinolaryngol. 2019 Mar;276(3):767-774. (PMID: 30600344)
Front Immunol. 2018 Jul 30;9:1705. (PMID: 30105019)
Curr Drug Targets Inflamm Allergy. 2005 Jun;4(3):329-34. (PMID: 16101542)

0 (Glycoproteins)
0 (Viral Vaccines)

Carp sprivivirus

Date Created: 20241209 Date Completed: 20241209 Latest Revision: 20241211

20250114

PMC11627376

10.1371/journal.ppat.1012744

39652527